This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 06/08/2020
Location: Pre-Recorded Video
Subject: Biotechnology Innovation Organization International Convention: FDA Priorities and Initiatives
FDA Participant/Group: PETER MARKS; WILSON BRYAN; JANET WOODCOCK;
Non FDA Participant/Group: Industry, government, academia, media and other registered guests

Event Date: 06/09/2020
Location: Teleconference
Subject: Respirators for Healthcare Use During COVID-19 Response
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, media, government, and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 06/09/2020
Location: Virtual
Subject: Biotechnology Innovation Organization (BIO) 2020 Panel: The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare professionals, academics, industry, patients, government officials, and media

Event Date: 06/10/2020
Location: Virtual
Subject: Precision Medicine 2020: Hyperindividualized Treatments
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, providers, patients, industry, and other stakeholders

Event Date: 06/10/2020
Location: Virtual
Subject: National Comprehensive Cancer Network Oncology Summit - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, industry, patients, government officials, and other stakeholders

Event Date: 06/11/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholder

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 06/10/2020
Location: Virtual
Subject: Pharmaceutical Care Management Association (PCMA) Webinar: FDA’s Leadership and Focus on the Drug Supply Chain in the COVID-19 Era
FDA Participant/Group: GURJEET GURAM; ANAND SHAH;
Non FDA Participant/Group: Ian Spatz, Manatt Health (Moderator)

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/08/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues of Mutual Interest
FDA Participant/Group: NINA ZIMDAHL;
Non FDA Participant/Group: Several executives from the food and beverage industry

Event Date: 06/09/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members from the produce industry, academia, and government

Event Date: 06/11/2020
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Representatives from consumer, trade union, and foodborne illness victim organizations

Event Date: 06/11/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members and executives from the National Association of State Departments of Agriculture

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/08/2020
Location: Virtual
Subject: Biotechnology Innovation Organization (BIO) Digital Meeting; BIO Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, media and other registered guests

Event Date: 06/09/2020
Location: Virtual
Subject: Biotechnology Innovation Organization (BIO) Digital Meeting; Developing Medical Products for COVID-19 in the Global Setting
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, media and other registered guests

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event